Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma

Annals of Surgical Oncology

Volumn 7, Issue 3, 2000, Pages 226-231

  Gershenwald, Jeffrey E ^a,b   Berman, Russell S ^a   Porter, Geoffrey ^a   Mansfield, Paul F ^a   Lee, Jeffrey E ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lymphadenectomy; Nodal basin failure; Sentinel lymph node

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PROGNOSIS;

EID: 0033993833     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02523658     Document Type: Article

References (24)

1. Ross M. The case for elective lymphadenectomy. Surg Oncol Clin N Am 1992;1:205-22.
2. Ross M, Balch C. The current management of cutaneous melanoma. Adv Surg 1990;24:139-200.
3. Balch C, Milton G, Cascinelli N, et al. Elective lymph node dissection: pros and cons. In. Balch C, Houghton A, Milton G, et al., eds. Cutaneous Melanoma. 2nd ed. Philadelphia: J.B. Lippincott, 1992:345.
4. Slingluff CL Jr, Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of regional lymph nodes in patients with melanoma. Ann Surg 1994;219:120-30.
5. Kelemen P, Wanek L, Morton D. Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases. Ann Surg Oncol 1999;6:139-43.
6. Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981;193:377-88.
7. Landis S, Murray T, Bolden S, Wingo P. Cancer statistics. CA Cancer J Clin 1999;49:8-31.
8. Miller EJ, Daly JM, Synnestvedt M, Schultz D, Elder D, Guerry D 4th. Loco-regional nodal relapse in melanoma. Surg Oncol 1992; 1:333-40.
9. Calabro A, Singletary S, Balch C. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989;124:1051-5.
10. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
11. Lefebvre JL, Coche-Dequeant B, Van JT, et al. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 1990;160:443-6.
12. Austin JR, Byers RM, Brown WD, Wolf P. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck 1996;18:107-17.
13. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
14. Ross M, Reintgen D, Balch C. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993;9:219-23.
15. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
16. Morton DL, Wen DR, Cochran A. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or "watch and wait." Surg Oncol Clin N Am 1992;1:247-59.
17. Reintgen D, Cruse C, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
18. Gershenwald JE, Tseng CH, Thompson W, et al. Improved sentinel lymph node localization in primary melanoma patients with the use of radiolabeled colloid. Surgery 1998;124:203-10.
19. Gadd M, Coit D. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992;127:1412-6.
20. Coates AS, Ingvar CI, Peterson-Schaefer K, et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991. J Am Coll Surg 1995;180:402-9.
21. Warso MA, Das Gupta TK. Melanoma recurrence in a previously dissected lymph node basin. Arch Surg 1994;129:252-5.
22. Monsour P, Sause W, Avent J, Noyes R. Local control following therapeutic nodal dissection for melanoma. J Surg Oncol 1993;54: 18-22.
23. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997;15:1039-51.
24. Coit D, Rogatko A, Brennan M. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: a multivariate analysis. Ann Surg 1991;214:627-36.